Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRD1 | P41143 | 7/20 | 0.71 |
| ▸ | OPRK1 | P41145 | 6/20 | 0.71 |
| ▸ | OPRM1 | P35372 | 6/20 | 0.71 |
| ▸ | MRGPRX2 | Q96LB1 | 2/20 | 0.64 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.64 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.64 |
| ▸ | ARRB1 | P49407 | 1/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Dihydromorphine SCHEMBL12402795 | 1.00 | OPRD1 (0.71) | OPRD1OPRK1OPRM1MRGPRX2SLC22A1 | |
| Dihydromorphine SCHEMBL2696539 | 1.00 | OPRD1 (0.71) | OPRD1OPRK1OPRM1MRGPRX2SLC22A1 | |
| Dihydromorphine SCHEMBL29394226 | 1.00 | OPRD1 (0.71) | OPRD1OPRK1OPRM1MRGPRX2SLC22A1 | |
| Dihydromorphine SCHEMBL19107002 | 1.00 | OPRD1 (0.71) | OPRD1OPRK1OPRM1MRGPRX2SLC22A1 | |
| Dihydromorphine SCHEMBL13348852 | 1.00 | OPRD1 (0.71) | OPRD1OPRK1OPRM1MRGPRX2SLC22A1 | |
| Dihydromorphine SCHEMBL19645038 | 1.00 | OPRD1 (0.71) | OPRD1OPRK1OPRM1MRGPRX2SLC22A1 | |
| Dihydromorphine SCHEMBL13380388 | 1.00 | OPRD1 (0.71) | OPRD1OPRK1OPRM1MRGPRX2SLC22A1 | |
| Dihydromorphine SCHEMBL19615483 | 1.00 | OPRD1 (0.71) | OPRD1OPRK1OPRM1MRGPRX2SLC22A1 | |
| Dihydromorphine SCHEMBL17025853 | 1.00 | OPRD1 (0.71) | OPRD1OPRK1OPRM1MRGPRX2SLC22A1 | |
| Dihydromorphine SCHEMBL15449768 | 1.00 | OPRD1 (0.71) | OPRD1OPRK1OPRM1MRGPRX2SLC22A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 11748 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260103736-A1 | Methods Of Improving Production Of Morphinan Alkaloids And Derivatives | ANTHEIA INC (US) | 2026-04-16 | — | — | US | claimed |
| EP-4724049-A1 | MODIFIED RELEASE FILL COMPOSITIONS FOR DOSAGE FORMS AND METHODS OF PREPARATION AND USE THEREOF | Catalent Ontario Limited (CA) | 2026-04-15 | — | — | EP | claimed |
| US-20250388939-A1 | RECOMBINANT HOST CELLS WITH IMPROVED PRODUCTION OF L-DOPA, DOPAMINE, S-NOROCLAURINE OR DERIVATIVES THEREOF | RIVER STONE BIOTECH APS (DK) | 2025-12-25 | — | — | US | claimed |
| US-20250319074-A1 | TREATMENT AND MANAGEMENT OF AUGMENTATION IN RESTLESS LEGS SYNDROME | UNIV EAST CAROLINA (US) | 2025-10-16 | — | — | US | claimed |
| US-20250283129-A1 | PROCESS | SUN PHARMACEUTICAL INDUSTRIES AUSTRALIA PTY LIMITED (AU) | 2025-09-11 | — | — | US | claimed |
| EP-4604968-A1 | ENHANCED NAD+ COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME | Bionadrx Holdings, Inc. (US) | 2025-08-27 | — | — | EP | claimed |
| US-20250255781-A1 | PROCESSES FOR PREPARATION OF 3-D PRINTED PHARMACEUTICAL PRODUCTS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2025-08-14 | — | — | US | claimed |
| US-12383743-B2 | Treatment of addiction and dependency | TACA JR ARTURO C (US) | 2025-08-12 | — | — | US | claimed |
| US-20250248938-A1 | MEDICAMENT DELIVERY FORMULATIONS, DEVICES AND METHODS | HONEYWELL INTERNATIONAL INC. (US) | 2025-08-07 | — | — | US | claimed |
| EP-4594342-A2 | METHODS OF IMPROVING PRODUCTION OF MORPHINAN ALKALOIDS AND DERIVATIVES | Antheia, Inc. (US) | 2025-08-06 | — | — | EP | claimed |
| EP-0548448-A1 | Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer | Euro-Celtique S.A. (LU) | 1993-06-30 | — | — | EP | claimed |
| US-4940586-A | Skin permeation enhancer compositions using sucrose esters | ALZA CORPORATION (US) | 1990-07-10 | — | — | US | claimed |
| US-4806341-A | BACKING LAYER, POLYMER MATRIX DISC WITH DRUG MICRODISPERSED THEREIN | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 1989-02-21 | — | — | US | claimed |
| EP-0046270-B1 | NOVEL DERIVATIVES OF BIO-AFFECTING PHENOLIC COMPOUNDS AND PHARMACEUTICAL COMPOSITION CONTAINING THEM | INTERx RESEARCH CORPORATION (US) | 1986-05-21 | — | — | EP | claimed |
| US-4464378-A | Method of administering narcotic antagonists and analgesics and novel dosage forms containing same | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) | 1984-08-07 | — | — | US | claimed |
| EP-0077393-A1 | NOVEL METHOD OF ADMINISTERING NARCOTIC ANTAGONISTS AND ANALGESICS AND NOVEL DOSAGE FORMS CONTAINING SAME | The University of Kentucky Research Foundation (US) | 1983-04-27 | — | — | EP | claimed |
| WO-1982003768-A1 | NOVEL METHOD OF ADMINISTERING NARCOTIC ANTAGONISTS AND ANALGESICS AND NOVEL DOSAGE FORMS CONTAINING SAME | UNIV KENTUCKY (US) | 1982-11-11 | — | — | WO | claimed |
| EP-0046270-A1 | Novel derivatives of bio-affecting phenolic compounds and pharmaceutical composition containing them | INTERx RESEARCH CORPORATION (US) | 1982-02-24 | — | — | EP | claimed |
| US-4126684-A | 4-AMINO-3-P-HALOPHENYLBUTYRIC ACIDS AND THEIR DERIVATIVES USED IN THE CONTROL OF NARCOTIC ABUSE | CIBA-GEIGY CORPORATION (US) | 1978-11-21 | — | — | US | claimed |
| US-4064228-A | Antigens and immunoassays for morphine and related 3-oxybenzomorphan compounds | BIOLOGICAL DEVELOPMENTS, INC. (US) | 1977-12-20 | — | — | US | claimed |